ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Intern - Kite Development - Process Development (Analytical Development) at Gilead Sciences - ApplyBlast

Intern - Kite Development - Process Development (Analytical Development)

Gilead Sciences

1 month ago

3.5 on Glassdoor

Santa Monica, California, United States

Hybrid

Internship

Intern

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This internship offers a unique opportunity to contribute to high-impact projects in cancer therapy development at an innovative biopharmaceutical company. The role involves working in a lab setting to execute study plans, analyze data, and document experiments while participating in professional development and leadership presentations. Interns will gain real-world experience and showcase their work through a final presentation near the conclusion of the program.

Responsibilities

Execute and analyze data in a lab setting with supervision
Generate SOPs and study reports by the end of the internship
Document experiments and present findings in a final presentation

Skills

About Gilead Sciences

gilead.com

Headquarters

Foster City, California, United States

Company Size

10001+ employees

Founded

1987

View Profile

Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.